Insulet Corporation (PODD)
USD 243.6
(-5.14%)
USD 243.6
(-5.14%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 1.85 Billion USD | 4.55% |
| 2022 | 1.77 Billion USD | 18.91% |
| 2021 | 1.49 Billion USD | 17.58% |
| 2020 | 1.26 Billion USD | 18.96% |
| 2019 | 1.06 Billion USD | 48.89% |
| 2018 | 716.64 Million USD | 8.87% |
| 2017 | 658.22 Million USD | 67.28% |
| 2016 | 393.49 Million USD | 63.23% |
| 2015 | 241.07 Million USD | 10.42% |
| 2014 | 218.32 Million USD | 33.65% |
| 2013 | 163.35 Million USD | 6.16% |
| 2012 | 153.88 Million USD | 11.36% |
| 2011 | 138.18 Million USD | 53.54% |
| 2010 | 90 Million USD | -24.24% |
| 2009 | 118.79 Million USD | 13.18% |
| 2008 | 104.95 Million USD | 172.85% |
| 2007 | 38.46 Million USD | -75.79% |
| 2006 | 158.9 Million USD | 91.72% |
| 2005 | 82.88 Million USD | 15.71% |
| 2004 | 71.63 Million USD | 101.16% |
| 2003 | 35.6 Million USD | -1.54% |
| 2002 | 36.16 Million USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q2 | 1.88 Billion USD | 2.72% |
| 2024 Q1 | 1.83 Billion USD | -1.2% |
| 2023 Q4 | 1.85 Billion USD | -0.25% |
| 2023 Q1 | 1.78 Billion USD | 0.65% |
| 2023 Q2 | 1.83 Billion USD | 2.55% |
| 2023 FY | 1.85 Billion USD | 4.55% |
| 2023 Q3 | 1.86 Billion USD | 1.54% |
| 2022 Q4 | 1.77 Billion USD | 2.1% |
| 2022 FY | 1.77 Billion USD | 18.91% |
| 2022 Q3 | 1.73 Billion USD | 2.77% |
| 2022 Q1 | 1.62 Billion USD | 8.71% |
| 2022 Q2 | 1.69 Billion USD | 4.24% |
| 2021 Q4 | 1.49 Billion USD | -0.57% |
| 2021 Q2 | 1.46 Billion USD | 16.72% |
| 2021 Q1 | 1.25 Billion USD | -1.14% |
| 2021 FY | 1.49 Billion USD | 17.58% |
| 2021 Q3 | 1.5 Billion USD | 2.49% |
| 2020 Q1 | 1.04 Billion USD | -1.67% |
| 2020 Q3 | 1.11 Billion USD | 4.91% |
| 2020 Q4 | 1.26 Billion USD | 13.78% |
| 2020 Q2 | 1.06 Billion USD | 1.35% |
| 2020 FY | 1.26 Billion USD | 18.96% |
| 2019 Q4 | 1.06 Billion USD | -4.55% |
| 2019 Q2 | 727.94 Million USD | -0.14% |
| 2019 Q3 | 1.11 Billion USD | 53.56% |
| 2019 Q1 | 728.98 Million USD | 1.72% |
| 2019 FY | 1.06 Billion USD | 48.89% |
| 2018 FY | 716.64 Million USD | 8.87% |
| 2018 Q4 | 716.64 Million USD | 4.11% |
| 2018 Q1 | 659.19 Million USD | 0.15% |
| 2018 Q2 | 659.7 Million USD | 0.08% |
| 2018 Q3 | 688.37 Million USD | 4.35% |
| 2017 FY | 658.22 Million USD | 67.28% |
| 2017 Q4 | 658.22 Million USD | 54.48% |
| 2017 Q3 | 426.09 Million USD | 7.98% |
| 2017 Q2 | 394.6 Million USD | 3.47% |
| 2017 Q1 | 381.37 Million USD | -3.08% |
| 2016 Q2 | 235.6 Million USD | 3.16% |
| 2016 Q4 | 393.49 Million USD | 1.39% |
| 2016 FY | 393.49 Million USD | 63.23% |
| 2016 Q1 | 228.37 Million USD | -5.27% |
| 2016 Q3 | 388.1 Million USD | 64.73% |
| 2015 Q4 | 241.07 Million USD | 1.3% |
| 2015 Q2 | 230.13 Million USD | 2.3% |
| 2015 FY | 241.07 Million USD | 10.42% |
| 2015 Q3 | 237.98 Million USD | 3.41% |
| 2015 Q1 | 224.97 Million USD | 3.04% |
| 2014 Q4 | 218.32 Million USD | -1.15% |
| 2014 FY | 218.32 Million USD | 33.65% |
| 2014 Q1 | 166.03 Million USD | 1.64% |
| 2014 Q2 | 247.44 Million USD | 49.03% |
| 2014 Q3 | 220.85 Million USD | -10.74% |
| 2013 Q1 | 151.35 Million USD | -1.64% |
| 2013 Q4 | 163.35 Million USD | -2.8% |
| 2013 Q3 | 168.07 Million USD | 13.7% |
| 2013 Q2 | 147.81 Million USD | -2.34% |
| 2013 FY | 163.35 Million USD | 6.16% |
| 2012 FY | 153.88 Million USD | 11.36% |
| 2012 Q1 | 145.06 Million USD | 4.98% |
| 2012 Q4 | 153.88 Million USD | 0.89% |
| 2012 Q3 | 152.52 Million USD | 5.78% |
| 2012 Q2 | 144.19 Million USD | -0.6% |
| 2011 Q4 | 138.18 Million USD | 4.42% |
| 2011 FY | 138.18 Million USD | 53.54% |
| 2011 Q3 | 132.34 Million USD | 0.19% |
| 2011 Q2 | 132.09 Million USD | 48.17% |
| 2011 Q1 | 89.14 Million USD | -0.95% |
| 2010 FY | 90 Million USD | -24.24% |
| 2010 Q1 | 118.11 Million USD | -0.57% |
| 2010 Q2 | 118 Million USD | -0.09% |
| 2010 Q3 | 116.34 Million USD | -1.41% |
| 2010 Q4 | 90 Million USD | -22.64% |
| 2009 Q1 | 104.39 Million USD | -0.53% |
| 2009 Q4 | 118.79 Million USD | 1.68% |
| 2009 Q3 | 116.82 Million USD | 13.66% |
| 2009 Q2 | 102.78 Million USD | -1.54% |
| 2009 FY | 118.79 Million USD | 13.18% |
| 2008 Q4 | 104.95 Million USD | 1.23% |
| 2008 Q2 | 103.28 Million USD | 141.16% |
| 2008 FY | 104.95 Million USD | 172.85% |
| 2008 Q1 | 42.82 Million USD | 11.34% |
| 2008 Q3 | 103.68 Million USD | 0.39% |
| 2007 Q1 | 160.75 Million USD | 1.17% |
| 2007 Q2 | 39.62 Million USD | -75.35% |
| 2007 Q3 | 39.3 Million USD | -0.79% |
| 2007 Q4 | 38.46 Million USD | -2.14% |
| 2007 FY | 38.46 Million USD | -75.79% |
| 2006 Q4 | 158.9 Million USD | 16.99% |
| 2006 Q3 | 135.82 Million USD | 0.0% |
| 2006 FY | 158.9 Million USD | 91.72% |
| 2005 FY | 82.88 Million USD | 15.71% |
| 2005 Q4 | 82.88 Million USD | 0.0% |
| 2004 FY | 71.63 Million USD | 101.16% |
| 2003 FY | 35.6 Million USD | -1.54% |
| 2002 FY | 36.16 Million USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Accelerate Diagnostics, Inc. | 51.25 Million USD | -3520.205% |
| BrainsWay Ltd. | 15.31 Million USD | -12016.364% |
| Cerus Corporation | 144.3 Million USD | -1185.827% |
| Envoy Medical, Inc. | 9.4 Million USD | -19635.163% |
| electroCore, Inc. | 8.94 Million USD | -20643.432% |
| Helius Medical Technologies, Inc. | 5.34 Million USD | -34634.182% |
| IceCure Medical Ltd | 4.24 Million USD | -43589.663% |
| Inogen, Inc. | 121.38 Million USD | -1428.645% |
| OrthoPediatrics Corp. | 72.56 Million USD | -2457.159% |
| Lucid Diagnostics Inc. | 29.58 Million USD | -6172.607% |
| Monogram Orthopaedics, Inc. | 3.18 Million USD | -58213.427% |
| MaxCyte, Inc. | 36.1 Million USD | -5038.893% |
| NeuroOne Medical Technologies Corporation | 1.84 Million USD | -100310.734% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -436199.764% |
| Orthofix Medical Inc. | 326.58 Million USD | -468.152% |
| PAVmed Inc | 57.13 Million USD | -3147.458% |
| Rapid Micro Biosystems, Inc. | 25.46 Million USD | -7187.044% |
| RxSight, Inc. | 22.18 Million USD | -8262.628% |
| Sight Sciences, Inc. | 46.43 Million USD | -3895.822% |
| SI-BONE, Inc. | 61.05 Million USD | -2939.312% |
| TELA Bio, Inc. | 59.16 Million USD | -3036.039% |
| Treace Medical Concepts, Inc. | 113.96 Million USD | -1528.074% |
| Vivos Therapeutics, Inc. | 10.31 Million USD | -17881.394% |
| Acutus Medical, Inc. | 54.83 Million USD | -3283.541% |
| Talis Biomedical Corporation | 29.22 Million USD | -6249.234% |
| Spectral AI, Inc. | 12.4 Million USD | -14862.503% |
| Nano-X Imaging Ltd. | 23.13 Million USD | -7920.662% |
| CVRx, Inc. | 39.28 Million USD | -4623.537% |
| DIH Holding US, Inc. Warrants | 11.95 Million USD | -15416.708% |
| PetVivo Holdings, Inc. | 2.42 Million USD | -76280.027% |
| Bioventus Inc. | 589.79 Million USD | -214.602% |
| Venus Concept Inc. | 107.1 Million USD | -1632.444% |
| TriSalus Life Sciences, Inc. | 51.66 Million USD | -3491.545% |
| LivaNova PLC | 1.15 Billion USD | -61.077% |
| 908 Devices Inc. | 37.49 Million USD | -4849.32% |
| Alphatec Holdings, Inc. | 703.48 Million USD | -163.757% |
| Nemaura Medical Inc. | 26.37 Million USD | -6934.423% |
| NeuroPace, Inc. | 86.99 Million USD | -2032.832% |
| LENSAR, Inc. | 22.4 Million USD | -8180.155% |
| Apyx Medical Corporation | 52.31 Million USD | -3446.581% |
| Cutera, Inc. | 518.12 Million USD | -258.121% |
| STRATA Skin Sciences, Inc. | 29.32 Million USD | -6226.718% |
| BioSig Technologies, Inc. | 4.68 Million USD | -39505.123% |
| Anika Therapeutics, Inc. | 58.36 Million USD | -3079.022% |
| ClearPoint Neuro, Inc. | 21.48 Million USD | -8535.052% |
| Integra LifeSciences Holdings Corporation | 2.19 Billion USD | 15.432% |
| Axonics, Inc. | 82.35 Million USD | -2152.941% |
| Outset Medical, Inc. | 190.91 Million USD | -871.898% |
| IRIDEX Corporation | 24.91 Million USD | -7347.62% |
| PROCEPT BioRobotics Corporation | 123.96 Million USD | -1396.793% |
| IRadimed Corporation | 20.73 Million USD | -8848.234% |
| Tivic Health Systems, Inc. | 1.67 Million USD | -110742.294% |
| INVO Bioscience, Inc. | 19.99 Million USD | -9179.838% |
| Telesis Bio, Inc. | 40.87 Million USD | -4439.672% |
| Viemed Healthcare, Inc. | 40.79 Million USD | -4448.883% |
| Varex Imaging Corporation | 668.6 Million USD | -177.52% |
| Quipt Home Medical Corp. | 136.29 Million USD | -1261.405% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -51845.689% |
| Pulmonx Corporation | 60.63 Million USD | -2960.063% |
| Dynatronics Corporation | 11.78 Million USD | -15651.12% |
| Modular Medical, Inc. | 2.27 Million USD | -81568.134% |
| ReShape Lifesciences Inc. | 4.06 Million USD | -45556.988% |
| Semler Scientific, Inc. | 6.27 Million USD | -29493.301% |
| InMode Ltd. | 75.91 Million USD | -2344.213% |
| Bruker Corporation | 2.83 Billion USD | 34.587% |
| Cytosorbents Corporation | 29.98 Million USD | -6087.997% |
| DexCom, Inc. | 4.19 Billion USD | 55.778% |
| Align Technology, Inc. | 2.45 Billion USD | 24.37% |
| Viveve Medical, Inc. | 10.84 Million USD | -17006.112% |
| ZimVie Inc. | 795.85 Million USD | -133.146% |
| Movano Inc. | 5.97 Million USD | -30969.993% |
| Cytek Biosciences, Inc. | 104.6 Million USD | -1673.816% |
| Nexalin Technology, Inc. | 425.28 Thousand USD | -436199.764% |
| DIH Holdings US, Inc. Class A Common Stock | 11.95 Million USD | -15416.708% |
| Tandem Diabetes Care, Inc. | 639.02 Million USD | -190.364% |
| Profound Medical Corp. | 12.66 Million USD | -14549.613% |
| enVVeno Medical Corporation | 2.43 Million USD | -76101.232% |
| Surmodics, Inc. | 65.82 Million USD | -2718.923% |
| iCAD, Inc. | 8 Million USD | -23090.854% |
| Nuwellis, Inc. | 6.78 Million USD | -27267.257% |
| Biotricity, Inc. | 35.91 Million USD | -5065.726% |
| iRhythm Technologies, Inc. | 223.04 Million USD | -731.887% |
| Aethlon Medical, Inc. | 2.47 Million USD | -74729.109% |
| InspireMD, Inc. | 8.14 Million USD | -22689.244% |
| PAVmed Inc. | 57.13 Million USD | -3147.458% |
| BIOLASE, Inc. | 35.34 Million USD | -5149.236% |
| Beyond Air, Inc. | 29.77 Million USD | -6131.738% |
| FONAR Corporation | 57.45 Million USD | -3129.339% |
| AxoGen, Inc. | 101.16 Million USD | -1734.187% |
| Vivani Medical, Inc. | 25.03 Million USD | -7311.328% |
| Tactile Systems Technology, Inc. | 87.79 Million USD | -2013.422% |
| Inari Medical, Inc. | 209.32 Million USD | -786.421% |
| UFP Technologies, Inc. | 118.04 Million USD | -1471.858% |
| QT Imaging Holdings, Inc. | 12.69 Million USD | -14521.18% |
| Heart Test Laboratories, Inc. | 2.18 Million USD | -84788.362% |
| Tenon Medical, Inc. | 5.56 Million USD | -33230.34% |
| Autonomix Medical, Inc. Common Stock | 1.77 Million USD | -104200.169% |
| Co-Diagnostics, Inc. | 17.63 Million USD | -10422.218% |
| AdaptHealth Corp. | 3.15 Billion USD | 41.154% |
| Sintx Technologies, Inc. | 6.59 Million USD | -28043.486% |
| NanoVibronix, Inc. | 2.68 Million USD | -68980.417% |
| Quanterix Corporation | 78.08 Million USD | -2276.287% |
| Inspira Technologies Oxy B.H.N. Ltd. | 3.57 Million USD | -51845.689% |
| Sensus Healthcare, Inc. | 4.88 Million USD | -37883.623% |
| Pacific Biosciences of California, Inc. | 1.04 Billion USD | -77.609% |
| TransMedics Group, Inc. | 568.84 Million USD | -226.187% |
| ReWalk Robotics Ltd. | 16.68 Million USD | -11022.767% |
| NeuroMetrix, Inc. | 1.33 Million USD | -139084.352% |
| Hyperfine, Inc. | 9.8 Million USD | -18833.673% |
| Establishment Labs Holdings Inc. | 250.24 Million USD | -641.47% |
| Biomerica, Inc. | 2.66 Million USD | -69577.056% |
| Bone Biologics Corporation | 831.4 Thousand USD | -223077.236% |
| AVITA Medical, Inc. | 19.86 Million USD | -9240.359% |
| Bluejay Diagnostics, Inc. | 1.97 Million USD | -93912.058% |
| Silk Road Medical, Inc | 114.15 Million USD | -1525.379% |